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Abstract
Purpose: Obesity is a well-known of risk factor for atherosclerosis and the amount of visceral adipose tissue is con-
sidered as an independent predictor of coronary artery disease (CAD). An aim of the study was to investigate the 
distribution of intrathoracic adipose tissue in morbidly obese patients.
Material and methods: Fifty-one patients with morbid obesity (BMI ≥ 40 kg/m2) and thirty controls were scanned in 
a coronary calcium scoring protocol. Control group consisted of patients scanned due to a clinical suspicion of CAD, 
who did not fulfill obesity criteria. The amount of adipose tissue was measured as epicardial adipose tissue (EAT) thick-
ness, pericoronary fat (PCF) thickness, total intra-pericardial fat (IPF) volume, and total intrathoracic fat (ITF) volume.
Results: Mean BMI of obese patients and controls was 47.3 and 26.5, respectively (p < 0.0001). Patients with obesity and 
controls did not differ with respect to mean EAT, mean PCF, and IPF. However, ITF was lower in obesity group than in 
control group (268 vs. 332 cm3, respectively; p < 0.03). Moreover, ROC analysis presented relation between obesity and 
the superior EAT thickness, PCF at LCX, mean PCF, ITF, and chest soft tissue (CST) thickness (p < 0.03). CST thickness 
of > 60 mm was the parameter that presented the strongest association with morbid obesity (AUC 0.95; p < 0.0001).
Conlcusions: Increased chest soft tissue thickness but not the increased intrathoracic adipose tissue volume was asso-
ciated with morbid obesity. Since the quantity of the pericardiac fat is not directly related to the obesity, its accumu-
lation may be related to a mechanism different than that of subcutaneous adipose tissue growth.
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Introduction
According to the WHO definition, obesity is a pathological 
accumulation of fat in the adipose tissue beyond physio-
logical needs and adaptability, which may lead to adverse 
health effects. The worldwide prevalence of obesity more 
than doubled between 1980 and 2014. Overall, about 13% 
of the world’s adult population (11% of men and 15% of 
women) were obese in 2014, which amounted to approxi-
mately 600 million individuals [1].
Because obesity is a risk factor for many significant dis-
orders, it has become a major concern in recent decades. 
This is particularly noticeable in highly developed coun-
tries, where a large percentage of the population is affected 
by overweight and obesity and where most of their negative 
consequences emerge. Obesity comorbidities, including 
dyslipidemia, non-insulin-dependent diabetes mellitus and 
hypertension, are risk factors of atherosclerosis eventually 
leading to coronary heart disease (CHD) or stroke. Exces-
sive adi posity is also related to certain types of cancer, gall-
bladder disease, osteoarthritis, gout and pulmonary diseas-
es, including sleep apnea [2].
The development of obesity may be triggered by var-
ious factors, e.g. endocrine diseases, use of certain medi-
cations, mental disorders or genetic factors. But in most 
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cases, the underlying reason is an excessive food intake 
combined with sedentary lifestyle. They both lead to a pos-
itive energy balance and finally to weight gain. Overweight 
and obese individuals differ not only in the amount of fat 
but also in its regional distribution. The main types of obe-
sity are “android obesity” (associated with intra-abdominal 
fat accumulation) and the “gynoid obesity”, in which fat 
is distributed more evenly, peripherally around the body. 
Nowadays, visceral adipose tissue (VAT) is considered as 
an active endocrine gland, secreting i.a. proinflammatory 
mediators. These factors may induce chronic inflamma-
tion and oxidative stress, which are believed to contribute 
to the development and growth of atherosclerotic plaques. 
Some trials have already confirmed that excessive visceral, 
abdominal fat is associated with accelerated progression of 
atherosclerosis and higher cardiovascular disease burden 
[3,4]. However, an increasing number of studies suggest 
that intra-thoracic fat (ITF) may exaggerate the progres-
sion of coronary atherosclerosis [5,6]. ITF, also referred to 
as pericardial adipose tissue (PAT), is classified as visceral 
fat and consists of epicardial and para-cardiac fat layers, 
separated by the pericardium. Although epicardial adipose 
tissue (EAT) and para-cardiac adipose tissue are thought 
to differ anatomically, embriologically, physiologically, bi-
omolecularly, and clinically [7], the emerging evidence has 
indicated that they both are equally metabolically active. 
These findings suggest that toxic effects exerted by ITF de-
pots on coronary arteries might be particularly significant 
in obese people.
It is recognized that android obesity poses a much 
greater health risk than the less serious gynoid obesity [8,9]. 
This relation is explained mainly by the fact that subcuta-
neous adipose tissue (SAT) is biologically less active than 
abdominal fat. Moreover, it has been discovered that re-
moving a large amount of subcutaneous fat by liposuction 
does not improve the CHD metabolic risk factors associat-
ed with abdominal obesity [10]. Probably that is why rela-
tively little attention is paid to the subcutaneous adipose tis-
sue. However, in patients with morbid obesity, its quantity 
may be large enough that it may also contribute to negative 
consequences such as insulin resistance [11]. Furthermore, 
new discoveries allowed to hypothesize about the existence 
of the so-called “obesity paradox”. It was already recognized 
in some cases of obesity, where moderate obesity apparent-
ly increased the survival rate in certain diseases (chronic 
kidney disease, congestive heart failure, chronic obstructive 
pulmonary disease, coronary artery disease) [12]. Explana-
tion for this phenomenon may be that the type and loca-
tion of adipose tissue and not the total amount of the body 
fat constitute a risk factor of those diseases. Indeed, recent 
studies show that in healthy subjects increased amounts 
of subcutaneous fat have a protective effect by inhibiting 
the development of atherosclerosis [13]. The phenomenon 
of obesity paradox encourages further research, particularly 
in the context of linking it to clusters of fat in specific areas 
of the body.
While the amount of intra-abdominal adipose tissue 
can be easily estimated by body mass index (BMI) com-
bined with the waist-hip ratio, it is more difficult to de-
termine the amount of fat deposited within the thoracic 
cavity. The aim of our study was to investigate the quanti-
ty and distribution of thoracic adipose tissue in morbidly 
obese patients using computed tomography.
Material and methods
Patients
A study group of 51 subjects, including 44 women and 
7 men, with morbid obesity (BMI ≥ 40 kg/m2) was re-
cruited from patients scheduled for bariatric surgery in 
our hospital. Exclusion criteria were: body weight over 
220 kg (scanner’s table limit), inability to fit the scanner’s 
gantry, dyspnea in supine position, previous coronary 
stenting or coronary surgery, arrhythmia or tachycardia, 
pregnancy, age below 18 years.
Due to possible ethical concerns, a control group of 
30 subjects was composed retrospectively from patients 
who were scanned due to a clinical suspicion of coronary 
artery disease and who did not fulfill obesity criteria. Exclu-
sion criteria were similar as in the study group.
Imaging methods
All subjects underwent an ECG-gated cardiac CT scan-
ning according to the coronary calcium scoring protocol 
using a 64-row Philips Brilliance unit [14,15]. No intra-
venous contrast media nor premedication were used. 
Standard Philips Brilliance Workstation was used to eval-
uate a number of morphological parameters for the quan-
tification of body fat. The quantity of epicardial fat was 
expressed as EAT thickness and peri-coronary fat thick-
ness (PCF) as well as intra-pericardial fat (IPF) volume. 
The total amount of fat inside the chest was measured 
as ITF volume. Due to limited FOV in our CS protocol, 
a rough estimate of subcutaneous fat was determined in 
a simplified manner on the basis of the CT scout view.
Epicardial fat thickness was measured on oblique 
MPR images. Reconstruction planes were located at the 
base of the ventricles and adjusted to be perpendicular 
to the long axis of the heart. Calipers were placed at the 
25% (EAT sup), 50% (EAT mid) and 75% (EAT inf) of the 
right ventricle’s wall, between myocardium and the vis-
ceral epicardium and perpendicular to the surface of the 
heart (Figure 1). The mean value of these measurements 
was also used in statistical analysis.
Pericoronary fat thickness was measured on standard 
axial scans. Calipers were placed in the regions of right 
coronary artery (PCF RCA), left coronary artery (PCF 
LCA) and the left circumflex (PCF LCX). The maximal 
distance between myocardium and the visceral epicardium 
was measured. To avoid overestimation of PCF thickness 
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due to obliquity, measurements were performed only on 
sections where surface of the heart was perpendicular to 
the slice plane. The mean value of these measurements was 
also used in statistical analysis (Figure 2).
In order to isolate voxels of adipose tissue for a vol-
umetric quantification, a density range from –200 to 
–30 HU was used. Intra-pericardial fat volume (IPF vol) 
(Figure 3) and intra-thoracic fat volume (ITF vol) (Figure 4) 
were calculated automatically after adequate fat depots were 
manually outlined slice-by-slice on axial scans. Tracing 
of the pericardium and the mediastinal boundary began at 
the level of pulmonary artery bifurcation and ended with 
the last slice on which pericardium was recognizable (IPF) 
or at the surface of the diaphragm (ITF).
Finally, we used CT scout views to measure total chest 
width and the distance between external outlines of ribs, 
slightly above the right dome of the diaphragm. The dif-
ference of these two measurements divided by 2 gave the 
approximate thickness of chest soft tissues (CST thick-
ness) (Figure 5).
Statistical analysis
Statistical analysis was performed using MedCalc v. 14 
(MedCalc Software bvba, NL). Normality of the data was 
tested using the Kolmogorov-Smirnov test. Differences in 
quantitative data were tested using the independent sam-
ples t-test. Comparison of qualitative data was performed 
using the Chi-squared test. P-value of 0.05 was consid-
ered statistically significant. ROC statistics and logistic 
regression analysis were used to detect the relation be-
tween obesity and the above-mentioned morphometric 
parameters.
Results
Both groups did not differ significantly in terms of gender 
and age distribution. Subjects from the study group were 
19 to 69 years old (mean 44.1), while the age of controls 
ranged from 30 to 71 years (mean 54.1). Mean BMI of 
obese patients and controls was 47.3 and 26.5, respectively 
(p < 0.0001). The results of chest fat quantitative assess-
ment in both groups are summarized in Table 1.
Patients with obesity and controls did not differ with 
respect to mean EAT, mean PCF and IPF volume. Only 
epicardial adipose tissue thickness at the middle level 
of the right ventricle’s front wall and the thickness of fat 
Figure 1. Measurement of the epicardial adipose tissue thickness (EAT). 
Reconstruction plane was adjusted to be perpendicular to the long axis of 
the heart and located at the base of the ventricles. Calipers were placed at 
the 25% (EAT sup), 50% (EAT mid) and 75% (EAT inf) of the right ventricle’s 
free wall, between myocardium and the visceral epicardium and perpendic-
ular to the surface of the heart
Figure 2. Measurement of the pericoronary fat thickness (PCF). Standard axial view is used. Calipers were placed in the regions of right coronary artery (PCF 
RCA), left coronary artery (PCF LCA) and the left circumflex (PCF LCX). Maximal distance between myocardium and the visceral epicardium was measured. To 
avoid overestimation of PCF thickness due to obliquity, measurements were done only on sections where surface of the heart was perpendicular to the slice plane
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Figure 3. Measurement of the intra-pericardial fat volume (IPF vol). Results 
obtained by manual, slice-by-slice tracing of the pericardium on axial sec-
tions, beginning at the level of pulmonary artery bifurcation and ending 
with the last slice on which pericardium was recognizable. Attenuation 
values from –200 HU to –30 HU were used to identify fat voxels
over the circumflex branch of left coronary artery were 
significantly higher in the study group than in the con-
trol group. However, ITF volume was lower in the obe-
sity group than in the control group (268 vs. 332 cm3, 
respectively; p < 0.03) (Table 2).
Furthermore, ROC analysis presented the relation 
between obesity and the superior EAT thickness, PCF 
around LCX, mean PCF, ITF and chest soft tissue thick-
ness (p < 0.03) (Table 3). CST thickness of > 60 mm was 
the parameter that presented the strongest association 
with morbid obesity (AUC 0.95; p < 0.0001) (Figure 6). 
In the logistic regression analysis, CST thickness was the 
only independent predictor of obesity with an odds ratio 
of 1.22 (95% CI: 1.04-1.42; p = 0.0144).
Figure 4. Measurement of the intra-thoracic fat volume (ITF vol). Results 
obtained by manual, slice-by slice tracing of the mediastinum boundary on 
axial sections, beginning at the level of pulmonary artery bifurcation and 
ending at the surface of the diaphragm. Attenuation values from –200 HU 
to –30 HU were used to identify fat voxels
Figure 5. Method of the approximate measurement of the CST thickness 
on the CT scout view
Table 1. Results of adipose tissue quantitative analysis and chest morphology measurements
Study group Control group
Mean value
(95% CI)
 Minimal 
value
Maximal 
value
Mean value
(95% CI)
Minimal 
value
Maximal
value
EAT inf (mm) 5.80 (5.04-6.55) 1.2 14.0 5.15 (4.41-5.89) 2.5 9.7
EAT mid (mm) 4.57 (3.92-5.22) 0.5 14.0 4.75 (3.89-5.61) 0.0 10.0
EAT sup (mm) 5.03 (4.43-5.62) 1.0 12.8 4.05 (3.40-4.71) 1.6 8.7
EAT mean (mm) 5.13 (4.50-5.76) 0.9 13.6 4.65 (4.02-5.27) 2.3 8.3
PCF LCA (mm) 7.31 (6.67-7.95) 2.6 13.1 11.47 (10.67-12.26) 7.9 17.4
PCF LCX (mm) 12.57 (11.93-13.21) 8.7 18.6 6.87 (6.07-7.66) 2.3 10.5
PCF RCA (mm) 15.04 (14.21-15.87) 7.0 22.9 14.52 (13.57-15.48) 9.6 19.0
PCF mean (mm) 11.64 (11.05-12.23) 7.3 18.2 10.95 (10.30-11.61) 7.5 15.3
IPF vol (cm3) 126.00 (109.00-145.00) 45 380.0 131.00 (108.00-155.00) 40.0 252.0
ITF vol (cm3) 268.00 (236.00-300.00) 99 664 .0 332.00 (284.00-381.00) 123.0 748.0
CST thickness (mm) 81.10 (72.80-89.40) 21.5 117.0 30.2 (24.7-35.7) 6.0 59.5
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Discussion
Our study showed that the amount of ITF is not di-
rectly related to obesity. Interestingly, the total ITF volume 
in morbidly obese patients appeared to be lower than that 
of patients with a suspicion of CAD. Moreover, chest soft 
tissue thickness determined on CT scout view was the 
only independent predictor of obesity.
As CST thickness is easy to assess, it might prove to be 
useful in clinical practice. However, it would require a prior 
confirmation of its association with, for example, cardiovas-
cular risk factors. Also, it represents a noteworthy observa-
tion because most obesity studies focus on the evaluation 
of visceral fat. Our study, in turn, showed that in patients 
with morbid obesity the amount of subcutaneous fat may 
be subject to proportionally greater growth. This observa-
tion requires further studies, since the available literature 
is insufficient in this area and brings different conclusions. 
For example, in the Framingham Heart Study, both BMI 
and waist circumference were strongly correlated with SAT 
and VAT after adjustment for age [16]. Whereas Prado 
et al. showed that patients with metabolic syndrome have 
significantly higher waist circumference, BMI, visceral fat 
thickness, preperitoneal circumference but not subcutane-
ous fat thickness, as compared to healthy individuals [17]. 
Figure 6. The ROC curve for the relationship between obesity and the chest 
soft tissues thickness in all patients
Table 2. Comparison of the amount of fat around the heart between 
the study group and the control group with respective levels of statistical 
significance of the difference
p-value
EAT sup 0.0376
EAT mid 0.7336
EAT inf 0.2509
EAT mean 0.3097
PCF LCA 0.3376
PCF LCX 0.0326
PCF RCA 0.3744
PCF mean 0.1181
IPF vol 0.7556
ITF vol 0.0225
Table 3. Analysis of the ROC curves for the relationship between obesity and the evaluated morphological parameters in all patients. Only statistically 
significant data are presented
AUC (95% CI) P-value Threshold Sensitivity Specificity
EAT sup 0.65 (0.53-0.75) 0.0239 > 4.7 56 70
ITF vol 0.66 (0.54-0.76) 0.0180 ≤ 298.7 73 67
PCF LCX 0.65 (0.53-0.75) 0.0200 > 12.5 50 77
PCF mean 0.70 (0.58-0.79) 0.0012 > 11.2 70 66
CST thickness 0.95 (0.88-0.99) < 0.0001 > 60.0 82 100
As regards ITF deposits, previous studies have shown that 
the thickness of epicardial adipose tissue of the right ven-
tricle, as assessed by echocardiography, is correlated with 
waist circumference, the amount of visceral fat of the abdo-
men, the values of diastolic blood pressure, insulin levels in 
serum, fasting insulin resistance and the severity of coro-
nary artery disease [18-20]. It seems, however, that CT due 
to its high spatial resolution, as compared to echocardiogra-
phy, should be a better modality for a reliable quantification 
of pericardial fat. An additional advantage of this method 
was that it was used in this study with ECG triggering. 
The triggering is a standard option in the calcium scoring 
protocol, and significantly reduces artifacts related to heart 
motion [14,15]. As shown by Gorter et al., measurements 
of fat volume by computed tomography have good repro-
ducibility and a low coefficient of variation ranging from 
3.0% to 5.0%. In contrast, only moderate repeatability of 
measurement was established for measuring the thickness 
of EAT in CT (CV of 11.0-23.4%) [21].
Our study, involving patients with morbid obesity, 
indicates that the amount of para-cardiac adipose is not 
directly related to obesity. This seems to confirm other 
mechanisms of subcutaneous and visceral fat accumu-
lation. The ROC curve analysis showed the relationship 
between obesity and the thickness of epicardial fat meas-
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ured at the level of the upper 25% of the RV anterior wall 
(EAT sup), a medium thickness of pericoronary fat (PCF 
mean), the thickness of fat around the LCX, the volume of 
ITF and also with the width of the soft tissues of the chest. 
Interestingly, the ITF volume was significantly higher in 
the control group. The explanation for this observation 
seems to be quite difficult. It may indicate that the pro-
cess of accumulating ITF in patients with morbid obesity 
occurs with a lower intensity than in non-obese patients. 
An alternative explanation would require a theory of se-
vere accumulation of thoracic fat in patients with coro-
nary atherosclerotic burden. It should be noted that the 
control group consisted of patients with a clinical indi-
cation for coronary CT angiography, and that they pre-
sented a significantly higher prevalence of other cardio-
vascular risk factors such as hypertension, smoking and 
dyslipidemia. This is an interesting observation, as it has 
been previously postulated that the accumulation of ad-
ipose tissue around the heart may provide a compensat-
ing mechanism for myo cardium that would otherwise be 
more vulnerable to ischemia. The basis for such a hypoth-
esis is the finding that infiltration of inflammatory cells, 
such as macrophages to the adipose tissue, can promote 
angiogenesis [22]. In other studies, various dependencies 
were detected. Mahabadi et al. analyzed the volume of fat 
in 3 locations (pericardial fat, ITF and visceral abdomi-
nal fat), which showed a close correlation with each other 
[23]. Liu et al., using data from the Jackson Heart Study, 
found that the amount of pericardial fat significantly cor-
related with BMI and the abdominal VAT [6]. Similarly, 
Gorter et al. reported that the amount of the epicardial 
adipose tissue was found to be associated with obesity [21]. 
Greif et al. found a significant increase in the volume of 
“pericardial fat” (PAT, approximately corresponding to 
ITF parameter in this paper) with age [24]. A similar cor-
relation was observed by Jeong et al. [20]. Moreover, in 
the study by Greif, female patients had a lower volume of 
pericardial fat compared to men irrespective of age [24]. 
Moreover, in a scientific evaluation of 3312 participants 
from the Framingham Heart Study by Thanassouliss et al., 
the average volume of pericardial fat (PFV) was higher in 
men (117.5 cm3) than in women (93.9 cm3) [25]. In the 
Yong’s study, pericardial fat area on CT sections correlated 
with age, HDL-cholesterol and the area occupied by the 
visceral fat on abdominal CT scans [26].
On the other hand Rosenquist et al. examined visceral 
and subcutaneous fat not quantitatively, but qualitatively. 
They showed that the attenuation coefficient expressed by 
Hounsfield units decreases in both visceral and subcuta-
neous fat with an increasing BMI. They also managed to 
show that a lower density of fat was correlated with an 
increased prevalence of cardiovascular risk factors. This 
relationship has proved to be the strongest in respect of 
visceral fat in women, but was also important for the sub-
cutaneous fat in men. Additionally, there was evidence for 
an interaction between the density and volume of fat in 
both women and men [27]. We recommend including this 
parameter, in addition to typical morphometry, in further 
studies on ITF.
A separate paragraph is required to discuss problems we 
encountered as we attempted to compare our results with 
other authors [28]. Firstly, the pericardial fat nomenclature 
found in the literature is ambiguous [29]. Anatomically, the 
pericardium is a double-layered, fibro-serous sac which 
covers the heart from the outside. The visceral pericar-
dium layer (being a part of epicardium) is adjacent to 
the surface of the cardiac muscle and is separated from 
it by a layer of epicardial fat. The parietal pericardium is 
closely fused with the fibrous pericardium, which forms 
the outer surface of the entire pericardium. The pericar-
dial sac is covered from the outside by mediastinal fat, 
while the space between visceral pericardium and pari-
etal pericardium (pericardial cavity) is only a potential 
space, containing trace amounts of fluid. Thus, the term 
“pericardial adipose tissue” [23,24,30-33] in our opinion 
is vague. It simply does not determine precisely which fat 
depot is referred to: whether on the outside of the peri-
cardial sac, inside the pericardium (between the visceral 
layer of the pericardium and the surface of myocardium), 
or both of these fat clusters? Unfortunately, we realized 
that there is disagreement in the anatomical nomenclature 
of fat that surrounds the heart, its components and their 
locations. For example, some authors define the fat con-
tained within the pericardium with the term “pericardial 
fat” [23,30-32]. For the same fat depot, other researchers 
have applied the term “epicardial fat” [21,24,26,34]. This is 
clearly a problem because in some papers, PAT is consid-
ered as a combination of epicardial adipose tissue and fat 
located outside of the pericardium [24,35,36], or only as 
extra-pericardial fat [7,33]. Similarly, the fat tissue locat-
ed outside the pericardium was referred to as paracardial 
[24,36], extrapericardial [34,37], pericardial [33], or ITF 
[23]. The combination of epicardial fat and extra-pericar-
dial adipose tissue was called, for example, the pericardial 
[24], thoracic [34,37] and ITF [30]. As a result, the full 
spectrum of varying and inconsistent terminology may 
be encountered in the literature. Consequently, it makes 
it difficult to compare the results between different studies 
and may introduce a lot of confusion, which leads to lively 
discussions between authors applying different termino-
logies [33,36].
The situation is also complicated by the fact that, in 
cardiac imaging methods (CT, MRI, echocardiography), 
the individual layers of fat are not always clearly distin-
guishable from one another – especially in lean people. 
However, data from the MESA used in the Jackson Heart 
Study and the work of Greif et al. [24] showed that the 
amount of epicardial adipose tissue correlates with the to-
tal amount of epicardial and extra-pericardial fat. More-
over, as Liu already pointed out, emerging reports seem 
to show that the two layers of adipose tissue are of equal 
metabolic activity [36]. Therefore, accurately distinguish-
Adam Lemanowicz, Waldemar Leszczyński, Grażyna Rusak et al.  
e74 © Pol J Radiol 2018; 83: e68-e75
ing both types of para-cardiac fat might not be so signif-
icant in order to determine their impact on other factors 
(e.g. atherosclerotic process).
Another aspect that should be taken into account, 
when comparing the results of different studies, is the 
lack of consensus between authors on the methodolo-
gy [28]. For example, in order to extract adipose tissue 
for quantitative analysis in CT, it is necessary to select 
a specific range of densities. Different authors use slightly 
different ranges: Nafakhi used the density range between 
–20 and –250 HU [31], Rosito and Mahabadi between 
–195 and –45 HU [23,30], Yong between –200 and –30 
HU [26], Liu between –190 and –30 HU [6], Greif be-
tween –250 and –30 HU [24]. Moreover, some authors 
used cross-axial sections to measure the volume of pa-
ra-cardiac fat [24,26], while some others used oblique 
reconstructions [21]. The slice thickness and their range 
also differ between authors. These methodological dif-
ferences can, of course, translate into differences in the 
measured amounts of para-cardiac adipose tissue in dif-
ferent works, and substantially reduce the possibility of 
a reliable comparison between their results. Therefore, 
in order to avoid mistakes and to allow comparisons 
between studies, an attempt to establish a consensus on 
the applicable nomenclature and research methodology 
should be made in the near future.
Conclusions
An increased chest soft tissue thickness but not an in-
creased intra-thoracic adipose tissue volume was associat-
ed with morbid obesity. Since the quantity of the pericar-
dial fat is not directly related to obesity, its accumulation 
may be related to a mechanism different than that seen in 
the case of subcutaneous adipose tissue growth.
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